Consistent with this, our results provide the first evidence that TMEM97 plays an important role in regulating oxidative stress and cell survival of human RPE, supporting a potential role of TMEM97 inhibition as a therapeutic strategy for treating AMD. Here, TMEM97 is linked to age-related macular degeneration.